ライフサイエンスコーパス: renal insufficiency

1 (diabetes mellitus, atrial fibrillation, and renal insufficiency).

2 ed grade 3 dose-limiting toxicity (seizures, renal insufficiency).

3 particularly in these patients who may have renal insufficiency.

4 tients exhibiting mild to moderate or severe renal insufficiency.

5 ibrosis in MRI contrast-treated rodents with renal insufficiency.

6 dings in irritable bowel syndrome and severe renal insufficiency.

7 ((99m)Tc-MAG3) scintigraphy in patients with renal insufficiency.

8 ion, arterial stiffening, heart failure, and renal insufficiency.

9 e for chronic diseases, namely, diabetes and renal insufficiency.

10 of the parathyroid gland after the onset of renal insufficiency.

11 e elderly, pregnant women, and patients with renal insufficiency.

12 buse and suffered relapse of proteinuria and renal insufficiency.

13 ibrosing disorder occurring in patients with renal insufficiency.

14 ears or 50 to 60 years with hypertension and renal insufficiency.

15 tting of drug initiation and the presence of renal insufficiency.

16 atic liver disease), antibiotic therapy, and renal insufficiency.

17 for renal toxicity and the dose modified for renal insufficiency.

18 nt-specific risk of developing postoperative renal insufficiency.

19 on who are at high risk of developing severe renal insufficiency.

20 lly approved for use in patients with severe renal insufficiency.

21 , symptomatic carotid stenosis, and baseline renal insufficiency.

22 s population and precedes the development of renal insufficiency.

23 hypertension is uncommon in SS disease with renal insufficiency.

24 osing entity of the skin in association with renal insufficiency.

25 es and is a major cause of acute and chronic renal insufficiency.

26 uscle mass, may be insensitive for detecting renal insufficiency.

27 pulse pressure seen with age, diabetes, and renal insufficiency.

28 heral arterial disease (PAD) in persons with renal insufficiency.

29 ion of their function, eventually leading to renal insufficiency.

30 c lupus erythematosus such as leukopenia and renal insufficiency.

31 ical and public health importance of chronic renal insufficiency.

32 y high prevalence of PAD among patients with renal insufficiency.

33 f 0.2 mmol/kg or higher and in patients with renal insufficiency.

34 lication is higher in patients with advanced renal insufficiency.

35 te renal function decline in women with mild renal insufficiency.

36 lications in the clinical setting of chronic renal insufficiency.

37 3 with 4306 lithium-exposed patients without renal insufficiency.

38 , in skin samples of patients suffering from renal insufficiency.

39 syndrome (PTMS), cardiovascular events, and renal insufficiency.

40 ns including hypertrophic cardiomyopathy and renal insufficiency.

41 a on patients with severe (stage 4 to 5 CKD) renal insufficiency.

42 or whether patients had diabetes mellitus or renal insufficiency.

43 phrogenic systemic fibrosis in patients with renal insufficiency.

44 ncy]; and OR 1.52, CI 1.32 to 1.76 [moderate renal insufficiency]).

45 s calculated using 0.0398 x (age) + 0.516 x (renal insufficiency) + 0.46 x (previous cerebrovascular

46 tion (6), intussusception (2), and transient renal insufficiency (1).

47 .5% vs 3.8%), diabetes (18.7% vs 11.1%), and renal insufficiency (1.7% vs 1.3%).

48 e mortality was 9% in patients with moderate renal insufficiency, 15% in patients with severe renal i

49 gical targets (24%), advanced age (16%), and renal insufficiency (16%).

50 litus (45.5% versus 30.8%; P<0.001), chronic renal insufficiency (19.2% versus 10.7%; P<0.001), and c

51 unction before CABG surgery developed severe renal insufficiency (229/8363).

52 es included coronary artery disease (51.5%), renal insufficiency (27.4%), diabetes mellitus (29.5%),

53 fraction <40% [4 points], anemia [2 points], renal insufficiency [3 points], triple-vessel disease [2

54 damage in SCA and the clinical correlates of renal insufficiency, 300 adult patients with SCA were st

55 nsion (77% versus 65%; P=0.006), and chronic renal insufficiency (34% versus 19%; P<0.0001).

56 abetes (58%), tobacco use (52%), and chronic renal insufficiency (39%).

57 i syndrome (38%; all with crystalline LCPT), renal insufficiency (83%), and proteinuria (98%).

58 lin-requiring diabetes mellitus and baseline renal insufficiency, a greater overall burden of coronar

59 nce interval [CI]: 1.01 to 1.04; p < 0.001), renal insufficiency (adjusted HR: 1.48; 95% CI: 1.07 to

60 I, 1.06-1.38), and with having no history of renal insufficiency (adjusted OR, 0.85; 95% CI, 0.75-0.9

61 Renal insufficiency after coronary artery bypass graft (

62 Sirolimus is used in patients with renal insufficiency after liver transplantation (LT) and

63 ocognitive dysfunction after OPCAB, and less renal insufficiency after OPCAB.

64 ment in renal function in LT recipients with renal insufficiency, although the results are limited by

65 renal function of patients who have chronic renal insufficiency, although these agents do not affect

66 hrombosis, a body weight >/=100 kg, moderate renal insufficiency, an age >/=75 years, and cancer.

67 elevant skeletal disease was associated with renal insufficiency and above 10-fold elevated fluoride

68 Renal insufficiency and advanced age were strongly assoc

69 The relationship between renal insufficiency and amino-terminal pro-brain natriur

70 rted almost exclusively in patients who have renal insufficiency and are exposed to contrast media fo

71 gated the relationship between pre-operative renal insufficiency and disease prognosis.

72 Heart failure patients with renal insufficiency and diuretic resistance have increas

73 ged echogenic kidneys, ultimately leading to renal insufficiency and end-stage renal disease.

74 riconazole, 300 mg twice daily, secondary to renal insufficiency and eventually continued treatment w

75 r CLKT by using three variables: duration of renal insufficiency and glomerular filtration rate measu

76 therapy until surgery is beneficial, whereas renal insufficiency and left main disease increase the r

77 ously known risk factors for mortality, like renal insufficiency and leukocytosis, the network identi

78 Renal insufficiency and LMD were independent predictors

79 urged to limit their potassium intake during renal insufficiency and may adhere to this principle aft

80 We sought to explore the association between renal insufficiency and mortality among women with heart

81 ction did not modify the association between renal insufficiency and mortality risk, but the use of a

82 s models to evaluate the association between renal insufficiency and mortality.

83 e potential for exacerbating hypertension or renal insufficiency and possible interactions with angio

84 tion due to bleeding, prolonged ventilation, renal insufficiency and primary graft dysfunction.

85 lantation (LT), but the role of pre-existing renal insufficiency and proteinuria remains unclear amon

86 injury such as left ventricular hypertrophy, renal insufficiency and proteinuria.

87 cations compared with those who did not have renal insufficiency and received a full dose.

88 njury in neutropenic mice resulted in milder renal insufficiency and significantly reduced mortality,

89 rkedly ameliorates albuminuria and abrogates renal insufficiency and the diabetic nodular glomerulosc

90 may be warranted in patients with underlying renal insufficiency and those who develop renal insuffic

91 2 showed decreased efficacy in patients with renal insufficiency, and 1 showed increased mortality co

92 l insufficiency, 15% in patients with severe renal insufficiency, and 16% in dialysis patients, compa

93 y, 25% were on balloon pump support, 20% had renal insufficiency, and 40% were on at least two inotro

94 of all cohort patients had at least moderate renal insufficiency, and 52% of all postoperative deaths

95 ntation, 49% had nephrotic syndrome, 68% had renal insufficiency, and 77% had hematuria.

96 ys), post-operative ventricular arrhythmias, renal insufficiency, and development of protein-losing e

97 Sema3a(+) mice develop massive proteinuria, renal insufficiency, and extensive nodular glomeruloscle

98 ucts, systemic hypertension, and progressive renal insufficiency, and in the liver with biliary dysge

99 ent predictors of complications include age, renal insufficiency, and individual operator.

100 uding hemodilution, inflammatory activation, renal insufficiency, and malnutrition.

101 th decompensated heart failure, mild chronic renal insufficiency, and renal function that had worsene

102 uch as circulatory failure, volume overload, renal insufficiency, and respiratory failure.

103 terminal prohormone of BNP, mild-to-moderate renal insufficiency, and systolic blood pressure greater

104 terminal prohormone of BNP, mild-to-moderate renal insufficiency, and systolic blood pressure greater

105 wound infection, myocardial infarction, and renal insufficiency, and the rates of these complication

106 ortality risk is increased in the setting of renal insufficiency, and the two most important risk pre

107 lower hemoglobin and creatinine levels; less renal insufficiency; and higher body mass indexes, diabe

108 e hypertension, diabetes, heart failure, and renal insufficiency; and were less likely to have insura

109 patients]; OR 2.54, CI 2.06 to 3.14 [severe renal insufficiency]; and OR 1.52, CI 1.32 to 1.76 [mode

110 cluded iron, folate, and B(12) deficiencies, renal insufficiency, anemia of chronic inflammation (ACI

111 age, female gender, diabetes, hypertension, renal insufficiency, anemia, no prior percutaneous coron

112 idence interval [CI] = 3.4-20.6; P < .0001), renal insufficiency (aOR = 2.4; 95% CI = 1.0-5.8; P = .0

113 It was concluded that early renal insufficiency (approximately stage 3 chronic kidne

114 Both moderate and severe renal insufficiency are associated with an increased odd

115 g requirement for mechanical ventilation and renal insufficiency, are negatively associated with surv

116 clusion of age, electrocardiogram normality, renal insufficiency, arrival mode, chief complaint, admi

117 fined as a GFR <60 mL/min/1.73 m2 and severe renal insufficiency as a GFR <30.

118 2, highest priority shifted to patients with renal insufficiency as a major component of their end-st

119 actory urinary retention, bladder stones, or renal insufficiency as a result of obstructive uropathy.

120 care, when possible, because of the risk of renal insufficiency associated with radical nephrectomy.

121 Patients with at least moderate renal insufficiency at baseline were eliminated from the

122 ad increased risk factors for posttransplant renal insufficiency at study start, relative to patients

123 cular repair (EVAR) in patients with chronic renal insufficiency because of the concern that the cont

124 hy (International Normalized Ratio>2.0), and renal insufficiency (blood urea nitrogen>40 mg/dL) were

125 Excluding from clinical trials patients with renal insufficiency but good performance status on the b

126 a from a control population of patients with renal insufficiency but who did not develop NSF.

127 Worsening renal insufficiency, cardiac arrest with cardiopulmonary

128 1 in an independent testing set, with 74% of renal insufficiency cases among the top two risk quintil

129 eport a form of amyloidosis characterized by renal insufficiency caused by a new apolipoprotein C-III

130 components of the Charlson index, diabetes, renal insufficiency, chronic obstructive pulmonary disea

131 is of participants enrolled into the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Stud

132 The Chronic Renal Insufficiency Cohort (CRIC) is a multicenter, pros

133 The Chronic Renal Insufficiency Cohort (CRIC) study enrolled 3939 pa

134 Chronic Renal Insufficiency Cohort (CRIC) Study participants who

135 quality with CKD progression in 431 Chronic Renal Insufficiency Cohort (CRIC) Study participants, of

136 studied 3483 people with CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study recruited from J

137 The Chronic Renal Insufficiency Cohort (CRIC) Study was established

138 ng 3093 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study who did not repo

139 a subset of 1214 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study, we determined t

140 In the Chronic Renal Insufficiency Cohort (CRIC) study, we evaluated 29

141 s of incident hospitalized HF in the Chronic Renal Insufficiency Cohort (CRIC), a multiethnic, multic

142 ages 2 through 4 who enrolled in the Chronic Renal Insufficiency Cohort between June 2003 and Septemb

143 in the United States enrolled in the Chronic Renal Insufficiency Cohort Study and followed up from Ma

144 ld to severe CKD who enrolled in the Chronic Renal Insufficiency Cohort Study between June 19, 2003,

145 The prospective Chronic Renal Insufficiency Cohort study recruited adults with a

146 of 942 participants with CKD in the Chronic Renal Insufficiency Cohort Study who had at least two mG

147 In 1431 participants from the Chronic Renal Insufficiency Cohort study, we measured 25-hydroxy

148 tions among 3487 participants of the Chronic Renal Insufficiency Cohort Study.

149 phate among 2879 participants in the Chronic Renal Insufficiency Cohort Study.

150 among 3939 patients with CKD in the Chronic Renal Insufficiency Cohort Study.

151 tion study among participants in the Chronic Renal Insufficiency Cohort Study.

152 isms [SNPs]) of CAC within the CRIC (Chronic Renal Insufficiency Cohort) study (N = 1,509; 57% Europe

153 prospective case-cohort study of the Chronic Renal Insufficiency Cohort, we measured FGF23 at two to

154 ng, accurate identification of patients with renal insufficiency combined with routine ABI measuremen

155 congestive heart failure, hypertension, and renal insufficiency compared with 133,699 patients treat

156 Patients with renal insufficiency, compensated hepatocellular function

157 nd LV contractility in children with chronic renal insufficiency (CRI) and children undergoing chroni

158 s is known about the epidemiology of chronic renal insufficiency (CRI) and its relationship to cardio

159 elop at the time of mild to moderate chronic renal insufficiency (CRI) and progress as renal function

160 o compare health of patients who had chronic renal insufficiency (CRI), were on dialysis, and were po

161 d as an ankle-brachial index (ABI) <0.9, and renal insufficiency, defined as an estimated creatinine

162 nt ESRD outpaced growth in prevalent chronic renal insufficiency, demonstrating that the ESRD epidemi

163 ia, transfusion with packed red blood cells, renal insufficiency, dialysis, or death.

164 s metabolic risk, arterial hypertension, and renal insufficiency drive left ventricular remodeling an

165 he rates of postoperative wound infection or renal insufficiency during this time period, but there w

166 y disease, diabetes mellitus, heart failure, renal insufficiency, ejection fraction, and aortic valve

167 Even moderate renal insufficiency (estimated GFR 30-59cc/min/1.73m(2))

168 Prevalence of renal insufficiency (estimated glomerular filtration rat

169 resonance (MR) imaging, all 13 patients had renal insufficiency (estimated glomerular filtration rat

170 Prevalent chronic renal insufficiency (estimated glomerular filtration rat

171 ve cardiac arrest (OR 2.49, (1.80-3.45)) and renal insufficiency/failure (OR 1.70 (1.32-2.18)).

172 troke, heart failure, myocardial infarction, renal insufficiency/failure, peripheral vascular disease

173 per 1.73 m(2)), 30% (n = 1742) had moderate renal insufficiency (GFR 30 to 59 ml/min per 1.73 m(2)),

174 o improve survival in patients with moderate renal insufficiency (GFR, 30 to 60 mL/min per 1.73 m2),

175 nal function at 1 year in LT recipients with renal insufficiency [glomerular filtration rate (GFR) <

176 Patients with renal insufficiency had spuriously low calcium measureme

177 pared with other risk factors for mortality, renal insufficiency had the highest population attributa

178 Renal insufficiency has been identified as a risk factor

179 Patients with both HF and renal insufficiency have a poor prognosis.

180 The lack of effect may be related to renal insufficiency, hemodynamic alterations, sodium bal

181 after PCI (HR: 2.31; 95% CL: 1.61 to 3.32), renal insufficiency (HR: 2.26; 95% CL: 1.51 to 3.39]), a

182 serum creatinine in a patient with baseline renal insufficiency, hypercholesterolemia, and hypophosp

183 Arterial hypertension, diabetes mellitus, renal insufficiency, hypercholesterolemia, gout, and obe

184 l fibrillation, prior myocardial infarction, renal insufficiency, hypertension, and need for intra-ao

185 as haemolytic anaemia, thrombocytopenia, and renal insufficiency; hypertension and neurological and p

186 Hypertension, renal insufficiency, hypertriglyceridemia, hypercholeste

187 holism, hypoalbuminemia, hyperbilirubinemia, renal insufficiency, hyponatremia, and prothrombin time

188 Moreover, hospitalized AHF patients may have renal insufficiency, hyponatremia, or an inadequate resp

189 ycystic kidney disease (ADPKD) progresses to renal insufficiency in >50% of patients and is character

190 For every 1000 adults with chronic renal insufficiency in 1978, 9 new cases of ESRD develop

191 in 1983, but every 1000 adults with chronic renal insufficiency in 1991 produced 16 new cases of ESR

192 f HGF is beneficial in ameliorating diabetic renal insufficiency in mice.

193 trongly associated with postoperative severe renal insufficiency included: age, gender, white blood c

194 er of adults age 20 to 74 years with chronic renal insufficiency increased from 2.6 to 3.9 million, a

195 Chronic renal insufficiency inexorably progresses in patients, s

196 ascular hemolysis, cutaneous leg ulceration, renal insufficiency, iron overload, and liver dysfunctio

197 s mellitus (IRR 1.44, 95% CI, 1.14-1.83) and renal insufficiency (IRR 1.36, 95% CI, 1.16-1.61), but l

198 Although renal insufficiency is a recognized risk factor for coro

199 Renal insufficiency is a risk factor for coronary heart

200 Renal insufficiency is associated with increased morbidi

201 Because renal insufficiency is common among patients with HCV, w

202 In conclusion, even moderate renal insufficiency is independently associated with pos

203 or current congestive heart failure, lack of renal insufficiency, ischemic electrocardiographic chang

204 merulopathy with proteinuria and progressive renal insufficiency, leading to ESRD.

205 CAD score were age, hyperlipidemia, chronic renal insufficiency, left ventricular function, and plas

206 uding prolonged drug effect in patients with renal insufficiency, limited experience with clinical la

207 include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or

208 ied 1445 adult lithium-treated patients with renal insufficiency, matched by risk set sampling 1 : 3

209 Renal insufficiency may be underrecognized in the genera

210 or bipolar disorder, risk for development of renal insufficiency may discourage their use.

211 ild hepatic synthetic dysfunction and marked renal insufficiency may have higher Model for End-Stage

212 a (mean 10.1 g/d; range 1.3 to 26.3 g/d) and renal insufficiency (mean serum creatinine 3.0 mg/dl; ra

213 ining 17 patients all have developed chronic renal insufficiency (mean serum creatinine, 2.4 mg/dl).

214 analysis identified diabetes, septic shock, renal insufficiency, mechanical ventilation, severity of

215 Even in the presence of renal insufficiency, NT-proBNP remained a valuable tool

216 ms of damage (such as subglottic stenosis or renal insufficiency) occur as the direct result of the d

217 However, the impact of milder degrees of renal insufficiency on death rates after lower extremity

218 The effects of renal insufficiency on NT-proBNP among patients with and

219 Few data are available on the impact of renal insufficiency on short-term operative outcomes aft

220 The impact of intervention for renal insufficiency on the prognosis of UC needs to be f

221 s to better estimate the prognostic value of renal insufficiency on UC, we performed a systematic rev

222 The effect of pre-operative renal insufficiency on urothelial carcinoma (UC) prognos

223 Chronic renal insufficiency, once established, tends to progress

224 duction in models of anemia caused by either renal insufficiency or chronic inflammation with enhance

225 (both in the fibrinogen group); 5 cases with renal insufficiency or failure (3 in the fibrinogen grou

226 cular accident or transient ischemic attack, renal insufficiency or failure, venous thromboembolism,

227 s not require adjustment in mild to moderate renal insufficiency or in any degree of hepatic impairme

228 y when poorly controlled or with concomitant renal insufficiency or obesity.

229 st studies excluded patients with hepatic or renal insufficiency or other serious comorbid conditions

230 static thyroid cancer, elderly patients with renal insufficiency or patients with renal failure.

231 ked less than 5 cigarettes/day, with chronic renal insufficiency or prior cancer, were excluded.

232 und that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control l

233 per 1.73 m(2)), and 8% (n = 484) had severe renal insufficiency or renal failure (GFR <30 ml/min per

234 retic use (OR, 1.13; 95% CI, 1.07-1.18), and renal insufficiency (OR, 1.11; 95% CI, 1.04-1.17) (multi

235 aneurysmal disease (OR, 9.5; P = 0.075), and renal insufficiency (OR, 7.1; P = 0.003) among its most

236 ry disease, hypertension, pulmonary disease, renal insufficiency, or atrial fibrillation.

237 is, particularly in the setting of diabetes, renal insufficiency, or body mass index <25 kg/m(2).

238 cially patients who are older, have baseline renal insufficiency, or have hypertension and/or diabete

239 on for congestive heart failure, progressive renal insufficiency, or the need for renal-replacement t

240 tion was similar regardless of hypertension, renal insufficiency, or treatment with ACE inhibitors (p

241 Renal insufficiency, PAH associated with connective tiss

242 is a progressive disorder occurring in some renal insufficiency patients exposed to gadolinium-based

243 Renal insufficiency predicts mortality among patients wh

244 concept pilot study in patients (n=40) with renal insufficiency preoperatively (defined as an estima

245 baseline blood pressure, history of chronic renal insufficiency, presence of diabetes mellitus, caus

246 lopurinol dose <300 mg in gout patients with renal insufficiency, QI 2 = uric acid check within 6 mon

247 bypass grafting surgery or in patients with renal insufficiency raises concern.

248 , patients with pre or posttransplant severe renal insufficiency remain more difficult to treat, due

249 Renal insufficiency remained associated with death after

250 Cardiovascular diseases and renal insufficiency represented 16.2% of the comorbiditi

251 IIIa antagonist use in patients with ACS and renal insufficiency resulted in increased bleeding event

252 Baseline renal insufficiency (RI) (estimated glomerular filtratio

253 Renal insufficiency (RI) is common after liver transplan

254 AD) explains the high cardiovascular risk of renal insufficiency (RI).

255 ion, metabolic or electrolyte abnormalities, renal insufficiency, sepsis, illness category, and need

256 ber of hemodynamic vulnerability indicators, renal insufficiency, single-ventricle physiology, and co

257 tical for risk standardization: patient age, renal insufficiency, single-ventricle physiology, proced

258 nt outcome benefit in patients with moderate renal insufficiency (stage 3 CKD), whereas there are ver

259 indicate that UC patients with pre-operative renal insufficiency tend to have higher recurrence rates

260 was discharged from hospital with only mild renal insufficiency that did not require renal replaceme

261 history of podagra, hyperuricemia, and mild renal insufficiency, the diagnosis and treatment of gout

262 diate BNP values and with obesity but not in renal insufficiency, the elderly, or patients with edema

263 ty report worse UC outcomes in patients with renal insufficiency, the results between the studies dif

264 d decreases plasma cystatin in patients with renal insufficiency undergoing cardiopulmonary bypass ca

265 roach to improving the care of patients with renal insufficiency undergoing lower extremity amputatio

266 pre-and post-operative care in patients with renal insufficiency undergoing lower extremity revascula

267 limb-threatening infection in patients with renal insufficiency undergoing revascularization.

268 an men, and had more hypertension, diabetes, renal insufficiency, unstable angina, and heart failure,

269 neumonia, ventilator dependence, progressive renal insufficiency, urinary tract infection, stroke, ve

270 best predicted the risk of developing severe renal insufficiency using multiple logistic regression,

271 Thus, 19-nor can suppress the progression of renal insufficiency via mediation of the TGF-beta signal

272 Renal insufficiency was a major predictor of mortality a

273 justment for potential confounders, moderate renal insufficiency was associated with a 37% increased

274 f nondairy animal protein in women with mild renal insufficiency was associated with a significantly

275 Renal insufficiency was associated with risk factors for

276 onal Kidney Foundation definitions, moderate renal insufficiency was defined as a GFR <60 mL/min/1.73

277 Renal insufficiency was defined as a serum creatinine le

278 Renal insufficiency was identified using the presence of

279 The association of ABI <0.9 with renal insufficiency was independent of potential confoun

280 Renal insufficiency was independently associated with el

281 Renal insufficiency was independently associated with fu

282 Renal insufficiency was strongly associated with mortali

283 in plasma samples from patients with chronic renal insufficiency were also found in the plasma of hea

284 accuracy of BNP improved when patients with renal insufficiency were excluded (area under receiver o

285 Patients with chronic renal insufficiency were further stratified into 2 diffe

286 graft dysfunction and the incidence of acute renal insufficiency were higher, and the mean intensive

287 hospital coronary artery bypass grafting and renal insufficiency were independently associated with l

288 with risk factors for CHF, and patients with renal insufficiency were more likely to have CHF (all p

289 the National Kidney Foundation criteria for renal insufficiency when the MDRD equations were used to

290 They also developed renal insufficiency, which became severe only shortly be

291 patients with glomerular disease and chronic renal insufficiency, which might inhibit or potentially

292 can control subjects, and the development of renal insufficiency, which was present in 21% of adults

293 ng renal insufficiency and those who develop renal insufficiency while undergoing stem cell mobilizat

294 teine has been recommended for patients with renal insufficiency who are to receive radiocontrast med

295 Patients with renal insufficiency who received dose modifications were

296 dosing and safety among patients with severe renal insufficiency, will continue to expand options for

297 ice developed hypertension, albuminuria, and renal insufficiency with arteriolar hyalinosis, mesangia

298 rs evaluated was the association of baseline renal insufficiency with future PAD events in the Heart

299 MFR is impaired in patients with renal insufficiency with normal regional perfusion and L

300 lar dysfunction, previous history of stroke, renal insufficiency, women, elderly patients, and those